Status:
UNKNOWN
Long-term Outcomes After Breast Cancer Liver Metastasis Surgery: an European, Retrospective, Snapshot Study
Lead Sponsor:
Hospital Miguel Servet
Collaborating Sponsors:
Spanish Association of Surgeons (AEC)
Conditions:
Breast Cancer
Liver Metastases
Eligibility:
All Genders
18-100 years
Brief Summary
Breast cancer ranks as the top leading malignant tumors among females, and also accounts for the most common cause of tumor related mortality in females worldwide. Approximately, 20-30% of breast canc...
Detailed Description
Breast cancer ranks as the top leading malignant tumors among females, and also accounts for the most common cause of tumor related mortality in female's worldwide . Approximately, 20-30% of breast ca...
Eligibility Criteria
Inclusion
- Patients ≥ 18 year old.
- Scheduled surgery for breast cancer liver metastases between January 1st 2010 and December 31st 2015
- American Society of Anesthesiologists (ASA) score I-III.
- They have signed the informed consent.
Exclusion
- Patients under 18 year old.
- ASA ≥ IV.
- Urgent surgery.
- Patients who have not signed the informed consent.
Key Trial Info
Start Date :
March 15 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 31 2021
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT04817813
Start Date
March 15 2021
End Date
July 31 2021
Last Update
March 26 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mario Serradilla Martín
Zaragoza, Spain, 50008